USAQ
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Sep 2 closing price
Capitalization
2.12M
WUXIF
Price
$15.00
Change
+$0.70 (+4.90%)
Updated
Sep 3 closing price
Capitalization
45.67B
Interact to see
Advertisement

USAQ vs WUXIF

Header iconUSAQ vs WUXIF Comparison
Open Charts USAQ vs WUXIFBanner chart's image
QHSLab
Price$0.19
Change-$0.00 (-0.00%)
Volume$1.85K
Capitalization2.12M
Wuxi Apptec
Price$15.00
Change+$0.70 (+4.90%)
Volume$234
Capitalization45.67B
USAQ vs WUXIF Comparison Chart in %
Loading...
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WUXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
USAQ vs. WUXIF commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USAQ is a Hold and WUXIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (USAQ: $0.19 vs. WUXIF: $15.00)
Brand notoriety: USAQ and WUXIF are both not notable
USAQ represents the Medical/Nursing Services, while WUXIF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: USAQ: 25% vs. WUXIF: 164%
Market capitalization -- USAQ: $2.12M vs. WUXIF: $45.67B
USAQ [@Medical/Nursing Services] is valued at $2.12M. WUXIF’s [@Medical Specialties] market capitalization is $45.67B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.6B. The average market capitalization across the [@Medical Specialties] industry is $10.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

USAQ’s FA Score shows that 0 FA rating(s) are green whileWUXIF’s FA Score has 2 green FA rating(s).

  • USAQ’s FA Score: 0 green, 5 red.
  • WUXIF’s FA Score: 2 green, 3 red.
According to our system of comparison, WUXIF is a better buy in the long-term than USAQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

USAQ’s TA Score shows that 2 TA indicator(s) are bullish while WUXIF’s TA Score has 0 bullish TA indicator(s).

  • USAQ’s TA Score: 2 bullish, 6 bearish.
  • WUXIF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, WUXIF is a better buy in the short-term than USAQ.

Price Growth

USAQ (@Medical/Nursing Services) experienced а -1.05% price change this week, while WUXIF (@Medical Specialties) price change was +4.90% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.08%. For the same industry, the average monthly price growth was +1.73%, and the average quarterly price growth was +23.90%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.74%. For the same industry, the average monthly price growth was +8.47%, and the average quarterly price growth was +10.21%.

Industries' Descriptions

@Medical/Nursing Services (-0.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+0.74% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WUXIF($45.7B) has a higher market cap than USAQ($2.12M). WUXIF YTD gains are higher at: 109.985 vs. USAQ (-24.194). WUXIF has higher annual earnings (EBITDA): 19.8B vs. USAQ (290K). WUXIF has more cash in the bank: 24.4B vs. USAQ (168K). USAQ has less debt than WUXIF: USAQ (1.58M) vs WUXIF (7.52B). WUXIF has higher revenues than USAQ: WUXIF (42.8B) vs USAQ (2.42M).
USAQWUXIFUSAQ / WUXIF
Capitalization2.12M45.7B0%
EBITDA290K19.8B0%
Gain YTD-24.194109.985-22%
P/E RatioN/A22.29-
Revenue2.42M42.8B0%
Total Cash168K24.4B0%
Total Debt1.58M7.52B0%
FUNDAMENTALS RATINGS
USAQ: Fundamental Ratings
USAQ
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
USAQWUXIF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
38%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
32%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WUXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX58.562.81
+5.04%
MoonLake Immunotherapeutics
ELBM0.91-0.01
-0.57%
Electra Battery Matls Corp
ELTX10.35-0.18
-1.71%
Elicio Therapeutics
IQV183.74-7.07
-3.71%
IQVIA Holdings
AEVA13.77-1.04
-7.02%
Aeva Technologies Inc

USAQ and

Correlation & Price change

A.I.dvisor tells us that USAQ and BIOQ have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USAQ and BIOQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USAQ
1D Price
Change %
USAQ100%
-1.05%
BIOQ - USAQ
27%
Poorly correlated
N/A
ADMT - USAQ
21%
Poorly correlated
-0.26%
TLTFF - USAQ
9%
Poorly correlated
+0.74%
WUXIF - USAQ
7%
Poorly correlated
N/A
XVIPF - USAQ
4%
Poorly correlated
N/A
More

WUXIF and

Correlation & Price change

A.I.dvisor tells us that WUXIF and BRSYF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WUXIF and BRSYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WUXIF
1D Price
Change %
WUXIF100%
N/A
BRSYF - WUXIF
27%
Poorly correlated
N/A
FDMDF - WUXIF
21%
Poorly correlated
N/A
USAQ - WUXIF
7%
Poorly correlated
-1.05%
BDSX - WUXIF
6%
Poorly correlated
+1.64%
BFLY - WUXIF
3%
Poorly correlated
-4.35%
More